Gene therapy approaches for treating rheumatoid arthritis

Clinical Orthopaedics and Related Research

Volumn 379, Issue SUPPL., 2000, Pages

  Ghivizzani, S C ^a   Oligino, T J ^a   Glorioso, J C ^a   Robbins, P D ^a   Evans, C H ^a  

^a Center for Advanced Orthopedic Studies   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GENE PRODUCT; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR; VIRUS PROTEIN; VIRUS VECTOR;

ADENOVIRUS; ANTIINFLAMMATORY ACTIVITY; CELLULAR IMMUNITY; CLINICAL TRIAL; CONFERENCE PAPER; CYTOKINE PRODUCTION; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; HERPES SIMPLEX VIRUS; HUMAN; HUMORAL IMMUNITY; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

EID: 0033775207     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/00003086-200010001-00038     Document Type: Conference Paper

References (50)

1. Adenovirus-mediated transfer of viral IL-10 gene inhibits murine collagen-induced arthritis
2. Regulation of synoviocyte proliferation, apoptosis, and invasion by the p53 tumor suppressor gene
3. Prevention of murine collagen-induced arthritis in the knee and ipsilateral paw by local expression of human interleukin- 1 receptor antagonist protein in the knee
4. Intraarticular expression of biologically active interleukin 1-receptor- antagonist protein by ex vivo gene transfer
5. Gene transfer to synoviocytes: Prospects for gene treatment of arthritis
6. Encapsulation in hollow fibres of xenogeneic cells engineered to secrete IL-4 or IL-13 ameliorates murine collagen-induced arthritis (CIA)
7. Matrix metalloproteinases and TIMPs: Properties and implications for the rheumatic diseases
8. Effects of growth factors on cartilage repair
9. Myoblast-mediated gene transfer to the joint
10. Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40
11. The role of CD40 and its ligand (gp39) in peripheral and central tolerance and its contribution to autoimmune disease
12. Gene therapy for rheumatic diseases
13. The promise of a new clinical trial - Intra-articular IL- 1 receptor antagonist
14. Clinical trial to assess the safety, feasibility, and efficacy of transferring a potentially anti-arthritic cytokine gene to human joints with rheumatoid arthritis
15. Synovial processes in rheumatoid arthritis
16. Treatment of murine lupus with CTLA4Ig
17. Direct adenovirus-mediated gene transfer of interleukin 1 and tumor necrosis factor alpha soluble receptors to rabbit knees with experimental arthritis has local and distal anti-arthritic effects
18. Direct retrovirus-mediated gene transfer to the synovium of the rabbit knee: Implications for arthritis gene therapy
19. Engineering herpes simplex virus vectors for human gene therapy
20. Feasibility of adenovirus-mediated nonsurgical synovectomy in collagen-induced arthritis-affected rhesus monkeys
21. Hypothesis: In vitro evidence for the invasive and tumor-like properties of the rheumatoid pannus
22. Cytokine therapy in rheumatoid arthritis
23. Suppression of collagen-induced arthritis through adenovirus-mediated transfer of a modified tumor necrosis factor alpha receptor gene
24. Direct adenoviral gene transfer of viral IL- 10 to rabbit knees with experimental arthritis ameliorates disease in both injected and contralateral control knees
25. Adenoviral vector-mediated overexpression of IL-4 in the knee joint of mice with collagen-induced arthritis prevents cartilage destruction
26. Prevention of collagen-induced arthritis by gene delivery of soluble p 75 tumour necrosis factor receptor
27. Pharmaceutical perspectives of nonviral gene therapy
28. Suppression of experimental arthritis by gene transfer of interleukin 1 receptor antagonist cDNA
29. Retrovirus mediated in vivo gene transfer to synovium in bacterial cell wall-induced arthritis in rats
30. NF-kappaB activation provides the potential link between inflammation and hyperplasia in the arthritic joint
31. Clonal expansion versus functional clonal inactivation: A co-stimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy
32. Direct gene delivery to synovium. An evaluation of potential vectors in vitro and in vivo
33. Intra-articular delivery of a herpes simplex virus IL- 1Ra gene vector reduces inflammation in a rabbit model of arthritis
34. Suppression of antigen-induced arthritis in rabbits by ex vivo gene therapy
35. Disease-inducible transgene expression from a recombinant adeno-associated virus vector in a rat arthritis model
36. Paradoxical effects of adenovirus-mediated blockade of TNF activity in murine collagen-induced arthritis
37. The genetic contribution to the pathogenesis of rheumatoid arthritis
38. Viral vectors for gene therapy
39. Adenoviral-mediated gene transfer to rabbit synovium in vivo
40. Inhibition of interleukin-1-induced effects in synoviocytes transduced with the human IL- 1 receptor antagonist cDNA using an adenoviral vector
41. Molecular lysis of synovial lining cells by in vivo herpes simplex virus-thymidine kinase gene transfer
42. Genetic basis for rheumatoid arthritis
43. Plasmid DNA encoding transforming growth factor-beta1 suppresses chronic disease in a streptococcal cell wall-induced arthritis model
44. Growth factor actions on articular cartilage
45. Using inhibitors of metalloproteinases to treat arthritis. Easier said than done?
46. Adenoviral transfer of the viral IL-10 gene periarticularly to mouse paws suppresses development of collagen-induced arthritis in both injected and uninjected paws
47. Bone morphogenetic protein and bone morphogenetic protein gene family in bone formation and repair
48. Gene transfer by adeno-associated virus vectors into the central nervous system
49. Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus
50. Amelioration of collagen-induced arthritis by CD95 (Apo-1/Fas)-ligand gene transfer